CD4 and neoplasm: Intratumoral CD4+ T cells are increasingly recognized as responsible for antitumor immune response and the production of inflammatory mediators that induce tumor growth, invasion, angiogenesis, and metastasis which are associated with clinical outcomes [9, 10].